Reclimet-PG 30 Tablet SR (Gliclazide (30mg) + Pioglitazone (15mg) + Metformin (500mg)

Reclimet-PG 30 Tablet SR is an anti-diabetic medicine that is used to treat type 2 diabetes mellitus. It helps control blood sugar levels in adults with diabetes.

Reclimet-PG 30 Tablet SR should be taken with food, preferably at the same time each day. Your doctor will decide what dose is best for you and this may change from time to time based on your blood sugar levels, keep taking this medicine, even if you feel well or your blood sugar levels are controlled. If you stop it without consulting your doctor, your blood sugar levels could rise and put you at risk of kidney damage, blindness, nerve problems, and loss of limbs.

Remember that it is only part of a treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by your doctor. Your lifestyle plays a big part in controlling diabetes.

The most common side effect of Reclimet-PG 30 Tablet SR is low blood glucose levels (hypoglycemia). Make sure you recognize the signs of low blood glucose levels (sweating, dizziness, headache) and know how to deal with them.

To prevent this, it’s important to have regular meals and always carry a fast-acting source of glucose such as sugary food or fruit juice with you. Drinking alcohol can also increase your risk of low blood sugar levels and should be avoided.

Other side effects that may be seen on taking this medicine include nausea, taste changes, diarrhea, stomach pain, headache, edema (swelling), blurred vision, bone fracture, and upper respiratory tract infections. Some people may find that they put on weight with this medicine.

You should not take it if you have type 1 diabetes mellitus, if you have diabetic ketoacidosis (high levels of acid in your blood), or if you have severe kidney or liver disease.

Before taking this medicine, tell your doctor if you have ever had heart disease. It may not be suitable. Pregnant or breastfeeding women should also consult their doctor before taking it.

Your blood sugar levels should be checked regularly and your doctor may also advise blood tests to monitor your blood cell counts and liver function.

“Innovative Tri-Therapy: Gliclazide 30mg + Pioglitazone 15mg + Metformin 500mg Elevating Diabetes Management”

Embark on a groundbreaking journey in diabetes management with the innovative tri-therapy of Gliclazide 30mg, Pioglitazone 15mg, and Metformin 500mg, collectively reshaping the paradigm of comprehensive glycemic control. Gliclazide stimulates insulin release, Pioglitazone enhances insulin sensitivity, and Metformin reduces glucose production, creating a dynamic synergy at 30mg, 15mg, and 500mg respectively.

This blog explores the uniqueness of Gliclazide 30mg + Pioglitazone 15mg + Metformin 500mg, unraveling their distinct roles, potential synergies, and how this innovative tri-therapy emerges as a trailblazer in the evolving landscape of diabetes care.

“The Trinity Code: Gliclazide 30mg + Pioglitazone 15mg + Metformin 500mg Deco

ding Personalized Diabetes Mastery”

Enter the realm of personalized diabetes mastery with the Trinity Code of Gliclazide 30mg, Pioglitazone 15mg, and Metformin 500mg, where each component decodes a tailored strategy for individualized diabetes care. Gliclazide’s insulin-boosting prowess,

Pioglitazone’s insulin-sensitizing effects, and Metformin’s multifaceted actions converge to create a unique code that aims for precision in glycemic control. The 30mg + 15mg + 500mg dosage, intricately calibrated, symbolizes a dynamic formulation that adapts to diverse insulin needs.

This blog delves into the Trinity Code of Gliclazide 30mg + Pioglitazone 15mg + Metformin 500mg, uncovering their collaborative benefits and the pivotal role they play in delivering optimal outcomes in diabetes care.

From its dosage rationale to practical insights, this discussion emphasizes the innovative and personalized approach that makes this tri-therapy a cornerstone in the evolving landscape of diabetes management.